Breaking News

Sunday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Conference/Events
Society for Robotic Surgery to hold a virtual symposium » 04:55
08/02/20
08/02
04:55
08/02/20
04:55
BDX

Becton Dickinson

$281.26 /

+7.205 (+2.63%)

, CNMD

Conmed

$82.46 /

-4.87 (-5.58%)

, EXAS

Exact Sciences

$94.76 /

-3.1 (-3.17%)

, TFX

Teleflex

$372.64 /

-11.37 (-2.96%)

, PCRX

Pacira

$52.62 /

-0.45 (-0.85%)

World Robotic Virtual…

World Robotic Virtual Symposium 2020 will be held on July 30-August 2. Webcast Link

ShowHide Related Items >><<
TFX Teleflex
$372.64 /

-11.37 (-2.96%)

PCRX Pacira
$52.62 /

-0.45 (-0.85%)

EXAS Exact Sciences
$94.76 /

-3.1 (-3.17%)

CNMD Conmed
$82.46 /

-4.87 (-5.58%)

BDX Becton Dickinson
$281.26 /

+7.205 (+2.63%)

BDX Becton Dickinson
$281.26 /

+7.205 (+2.63%)

07/09/20
Fly Intel: Top five analyst upgrades
07/09/20 Barclays
Barclays upgrades Becton Dickinson to Overweight on 'window of opportunity'
07/09/20 Barclays
Becton Dickinson upgraded to Overweight from Equal Weight at Barclays
07/02/20 Wells Fargo
Becton rallies after Wells says rapid COVID test may come very soon
CNMD Conmed
$82.46 /

-4.87 (-5.58%)

07/29/20 Piper Sandler
Conmed price target raised to $95 from $90 at Piper Sandler
04/30/20 Piper Sandler
Conmed price target lowered to $90 from $110 at Piper Sandler
04/20/20 Piper Sandler
Conmed news positive for company, entire sector, says Piper Sandler
03/20/20 Piper Sandler
Conmed results to bounce back 'fairly quickly,' says Piper Sandler
EXAS Exact Sciences
$94.76 /

-3.1 (-3.17%)

07/31/20 Benchmark
Exact Sciences price target raised to $110 from $90 at Benchmark
07/31/20 Citi
Exact Sciences price target raised to $120 from $110 at Citi
07/23/20 Evercore ISI
Evercore ISI says Humana pact relates to FIT testing, not Exact's Cologuard
07/23/20 Evercore ISI
Humana plans could boost Exact's growth as much as 12%, says Evercore ISI
TFX Teleflex
$372.64 /

-11.37 (-2.96%)

07/30/20 Piper Sandler
Teleflex selloff on DOJ investigation should be bought, says Piper Sandler
06/09/20 Wells Fargo
Teleflex price target raised to $425 from $375 at Wells Fargo
06/04/20 SVB Leerink
Teleflex price target raised to $425 from $400 at SVB Leerink
05/01/20 Piper Sandler
Teleflex price target lowered to $375 from $425 at Piper Sandler
PCRX Pacira
$52.62 /

-0.45 (-0.85%)

07/13/20 H.C. Wainwright
Pacira price target raised to $68 from $63 at H.C. Wainwright
07/10/20 Jefferies
Pacira price target raised to $69 from $53 at Jefferies
07/06/20 Needham
Pacira price target raised to $64 from $52 at Needham
07/06/20 Piper Sandler
Pacira price target raised to $65 from $49 at Piper Sandler
TFX Teleflex
$372.64 /

-11.37 (-2.96%)

PCRX Pacira
$52.62 /

-0.45 (-0.85%)

EXAS Exact Sciences
$94.76 /

-3.1 (-3.17%)

CNMD Conmed
$82.46 /

-4.87 (-5.58%)

BDX Becton Dickinson
$281.26 /

+7.205 (+2.63%)

  • 21
    May
PCRX Pacira
$52.62 /

-0.45 (-0.85%)

EXAS Exact Sciences
$94.76 /

-3.1 (-3.17%)

BDX Becton Dickinson
$281.26 /

+7.205 (+2.63%)

EXAS Exact Sciences
$94.76 /

-3.1 (-3.17%)

Saturday
Conference/Events
Society for Robotic Surgery to hold a virtual symposium » 04:55
08/01/20
08/01
04:55
08/01/20
04:55
BDX

Becton Dickinson

$281.26 /

+7.205 (+2.63%)

, CNMD

Conmed

$82.46 /

-4.87 (-5.58%)

, EXAS

Exact Sciences

$94.76 /

-3.1 (-3.17%)

, TFX

Teleflex

$372.64 /

-11.37 (-2.96%)

, PCRX

Pacira

$52.62 /

-0.45 (-0.85%)

World Robotic Virtual…

World Robotic Virtual Symposium 2020 will be held on July 30-August 2. Webcast Link

ShowHide Related Items >><<
TFX Teleflex
$372.64 /

-11.37 (-2.96%)

PCRX Pacira
$52.62 /

-0.45 (-0.85%)

EXAS Exact Sciences
$94.76 /

-3.1 (-3.17%)

CNMD Conmed
$82.46 /

-4.87 (-5.58%)

BDX Becton Dickinson
$281.26 /

+7.205 (+2.63%)

BDX Becton Dickinson
$281.26 /

+7.205 (+2.63%)

07/09/20
Fly Intel: Top five analyst upgrades
07/09/20 Barclays
Barclays upgrades Becton Dickinson to Overweight on 'window of opportunity'
07/09/20 Barclays
Becton Dickinson upgraded to Overweight from Equal Weight at Barclays
07/02/20 Wells Fargo
Becton rallies after Wells says rapid COVID test may come very soon
CNMD Conmed
$82.46 /

-4.87 (-5.58%)

07/29/20 Piper Sandler
Conmed price target raised to $95 from $90 at Piper Sandler
04/30/20 Piper Sandler
Conmed price target lowered to $90 from $110 at Piper Sandler
04/20/20 Piper Sandler
Conmed news positive for company, entire sector, says Piper Sandler
03/20/20 Piper Sandler
Conmed results to bounce back 'fairly quickly,' says Piper Sandler
EXAS Exact Sciences
$94.76 /

-3.1 (-3.17%)

07/31/20 Benchmark
Exact Sciences price target raised to $110 from $90 at Benchmark
07/31/20 Citi
Exact Sciences price target raised to $120 from $110 at Citi
07/23/20 Evercore ISI
Evercore ISI says Humana pact relates to FIT testing, not Exact's Cologuard
07/23/20 Evercore ISI
Humana plans could boost Exact's growth as much as 12%, says Evercore ISI
TFX Teleflex
$372.64 /

-11.37 (-2.96%)

07/30/20 Piper Sandler
Teleflex selloff on DOJ investigation should be bought, says Piper Sandler
06/09/20 Wells Fargo
Teleflex price target raised to $425 from $375 at Wells Fargo
06/04/20 SVB Leerink
Teleflex price target raised to $425 from $400 at SVB Leerink
05/01/20 Piper Sandler
Teleflex price target lowered to $375 from $425 at Piper Sandler
PCRX Pacira
$52.62 /

-0.45 (-0.85%)

07/13/20 H.C. Wainwright
Pacira price target raised to $68 from $63 at H.C. Wainwright
07/10/20 Jefferies
Pacira price target raised to $69 from $53 at Jefferies
07/06/20 Needham
Pacira price target raised to $64 from $52 at Needham
07/06/20 Piper Sandler
Pacira price target raised to $65 from $49 at Piper Sandler
TFX Teleflex
$372.64 /

-11.37 (-2.96%)

PCRX Pacira
$52.62 /

-0.45 (-0.85%)

EXAS Exact Sciences
$94.76 /

-3.1 (-3.17%)

CNMD Conmed
$82.46 /

-4.87 (-5.58%)

BDX Becton Dickinson
$281.26 /

+7.205 (+2.63%)

  • 21
    May
PCRX Pacira
$52.62 /

-0.45 (-0.85%)

EXAS Exact Sciences
$94.76 /

-3.1 (-3.17%)

BDX Becton Dickinson
$281.26 /

+7.205 (+2.63%)

EXAS Exact Sciences
$94.76 /

-3.1 (-3.17%)

Friday
Conference/Events
Society for Robotic Surgery to hold a virtual symposium » 04:55
07/31/20
07/31
04:55
07/31/20
04:55
BDX

Becton Dickinson

$274.05 /

-2.22 (-0.80%)

, CNMD

Conmed

$87.33 /

+0.86 (+0.99%)

, EXAS

Exact Sciences

$97.86 /

+3.38 (+3.58%)

, TFX

Teleflex

$384.01 /

-19.34 (-4.79%)

, PCRX

Pacira

$53.07 /

+0.53 (+1.01%)

World Robotic Virtual…

World Robotic Virtual Symposium 2020 will be held on July 30-August 2. Webcast Link

ShowHide Related Items >><<
TFX Teleflex
$384.01 /

-19.34 (-4.79%)

PCRX Pacira
$53.07 /

+0.53 (+1.01%)

EXAS Exact Sciences
$97.86 /

+3.38 (+3.58%)

CNMD Conmed
$87.33 /

+0.86 (+0.99%)

BDX Becton Dickinson
$274.05 /

-2.22 (-0.80%)

BDX Becton Dickinson
$274.05 /

-2.22 (-0.80%)

07/09/20
Fly Intel: Top five analyst upgrades
07/09/20 Barclays
Barclays upgrades Becton Dickinson to Overweight on 'window of opportunity'
07/09/20 Barclays
Becton Dickinson upgraded to Overweight from Equal Weight at Barclays
07/02/20 Wells Fargo
Becton rallies after Wells says rapid COVID test may come very soon
CNMD Conmed
$87.33 /

+0.86 (+0.99%)

07/29/20 Piper Sandler
Conmed price target raised to $95 from $90 at Piper Sandler
04/30/20 Piper Sandler
Conmed price target lowered to $90 from $110 at Piper Sandler
04/20/20 Piper Sandler
Conmed news positive for company, entire sector, says Piper Sandler
03/20/20 Piper Sandler
Conmed results to bounce back 'fairly quickly,' says Piper Sandler
EXAS Exact Sciences
$97.86 /

+3.38 (+3.58%)

07/23/20 Evercore ISI
Evercore ISI says Humana pact relates to FIT testing, not Exact's Cologuard
07/23/20 Evercore ISI
Humana plans could boost Exact's growth as much as 12%, says Evercore ISI
06/25/20 Citi
Citi opens 'positive catalyst watch' on Exact Sciences, boosts target
05/13/20 Evercore ISI
Exact Sciences comments imply volumes last week down 40% YoY, says Evercore ISI
TFX Teleflex
$384.01 /

-19.34 (-4.79%)

07/30/20 Piper Sandler
Teleflex selloff on DOJ investigation should be bought, says Piper Sandler
06/09/20 Wells Fargo
Teleflex price target raised to $425 from $375 at Wells Fargo
06/04/20 SVB Leerink
Teleflex price target raised to $425 from $400 at SVB Leerink
05/01/20 Piper Sandler
Teleflex price target lowered to $375 from $425 at Piper Sandler
PCRX Pacira
$53.07 /

+0.53 (+1.01%)

07/13/20 H.C. Wainwright
Pacira price target raised to $68 from $63 at H.C. Wainwright
07/10/20 Jefferies
Pacira price target raised to $69 from $53 at Jefferies
07/06/20 Needham
Pacira price target raised to $64 from $52 at Needham
07/06/20 Piper Sandler
Pacira price target raised to $65 from $49 at Piper Sandler
TFX Teleflex
$384.01 /

-19.34 (-4.79%)

PCRX Pacira
$53.07 /

+0.53 (+1.01%)

EXAS Exact Sciences
$97.86 /

+3.38 (+3.58%)

CNMD Conmed
$87.33 /

+0.86 (+0.99%)

BDX Becton Dickinson
$274.05 /

-2.22 (-0.80%)

  • 21
    May
PCRX Pacira
$53.07 /

+0.53 (+1.01%)

EXAS Exact Sciences
$97.86 /

+3.38 (+3.58%)

BDX Becton Dickinson
$274.05 /

-2.22 (-0.80%)

EXAS Exact Sciences
$97.86 /

+3.38 (+3.58%)

Thursday
Conference/Events
Society for Robotic Surgery to hold a virtual symposium » 09:15
07/30/20
07/30
09:15
07/30/20
09:15
BDX

Becton Dickinson

$276.27 /

+3.18 (+1.16%)

, CNMD

Conmed

$86.47 /

+3.665 (+4.43%)

, EXAS

Exact Sciences

$94.48 /

-0.32 (-0.34%)

, TFX

Teleflex

$403.35 /

+18.1 (+4.70%)

, PCRX

Pacira

$52.54 /

+0.61 (+1.17%)

World Robotic Virtual…

World Robotic Virtual Symposium 2020 will be held on July 30-August 2. Webcast Link

ShowHide Related Items >><<
TFX Teleflex
$403.35 /

+18.1 (+4.70%)

PCRX Pacira
$52.54 /

+0.61 (+1.17%)

EXAS Exact Sciences
$94.48 /

-0.32 (-0.34%)

CNMD Conmed
$86.47 /

+3.665 (+4.43%)

BDX Becton Dickinson
$276.27 /

+3.18 (+1.16%)

BDX Becton Dickinson
$276.27 /

+3.18 (+1.16%)

07/09/20
Fly Intel: Top five analyst upgrades
07/09/20 Barclays
Barclays upgrades Becton Dickinson to Overweight on 'window of opportunity'
07/09/20 Barclays
Becton Dickinson upgraded to Overweight from Equal Weight at Barclays
07/02/20 Wells Fargo
Becton rallies after Wells says rapid COVID test may come very soon
CNMD Conmed
$86.47 /

+3.665 (+4.43%)

07/29/20 Piper Sandler
Conmed price target raised to $95 from $90 at Piper Sandler
04/30/20 Piper Sandler
Conmed price target lowered to $90 from $110 at Piper Sandler
04/20/20 Piper Sandler
Conmed news positive for company, entire sector, says Piper Sandler
03/20/20 Piper Sandler
Conmed results to bounce back 'fairly quickly,' says Piper Sandler
EXAS Exact Sciences
$94.48 /

-0.32 (-0.34%)

07/23/20 Evercore ISI
Evercore ISI says Humana pact relates to FIT testing, not Exact's Cologuard
07/23/20 Evercore ISI
Humana plans could boost Exact's growth as much as 12%, says Evercore ISI
06/25/20 Citi
Citi opens 'positive catalyst watch' on Exact Sciences, boosts target
05/13/20 Evercore ISI
Exact Sciences comments imply volumes last week down 40% YoY, says Evercore ISI
TFX Teleflex
$403.35 /

+18.1 (+4.70%)

06/09/20 Wells Fargo
Teleflex price target raised to $425 from $375 at Wells Fargo
06/04/20 SVB Leerink
Teleflex price target raised to $425 from $400 at SVB Leerink
05/01/20 Piper Sandler
Teleflex price target lowered to $375 from $425 at Piper Sandler
04/03/20 Raymond James
Teleflex price target lowered to $360 from $450 at Raymond James
PCRX Pacira
$52.54 /

+0.61 (+1.17%)

07/13/20 H.C. Wainwright
Pacira price target raised to $68 from $63 at H.C. Wainwright
07/10/20 Jefferies
Pacira price target raised to $69 from $53 at Jefferies
07/06/20 Needham
Pacira price target raised to $64 from $52 at Needham
07/06/20 Piper Sandler
Pacira price target raised to $65 from $49 at Piper Sandler
TFX Teleflex
$403.35 /

+18.1 (+4.70%)

PCRX Pacira
$52.54 /

+0.61 (+1.17%)

EXAS Exact Sciences
$94.48 /

-0.32 (-0.34%)

CNMD Conmed
$86.47 /

+3.665 (+4.43%)

BDX Becton Dickinson
$276.27 /

+3.18 (+1.16%)

  • 21
    May
PCRX Pacira
$52.54 /

+0.61 (+1.17%)

EXAS Exact Sciences
$94.48 /

-0.32 (-0.34%)

BDX Becton Dickinson
$276.27 /

+3.18 (+1.16%)

EXAS Exact Sciences
$94.48 /

-0.32 (-0.34%)

Wednesday
Recommendations
Conmed price target raised to $95 from $90 at Piper Sandler » 21:00
07/29/20
07/29
21:00
07/29/20
21:00
CNMD

Conmed

$86.47 /

+3.665 (+4.43%)

Piper Sandler analyst…

Piper Sandler analyst Matt O'Brien raised the firm's price target on Conmed to $95 from $90 and keeps an Overweight rating on the shares. The company's Q2 results topped "depressed" Q2 estimates and while the management is not offering guidance, Q3 will likely "rise meaningfully", the analyst tells investors in a research note. O'Brien adds that with COVID-19 having accelerated several cost savings initiatives, Conmed's operating margin should improve to levels above where the company has previously guided.

ShowHide Related Items >><<
CNMD Conmed
$86.47 /

+3.665 (+4.43%)

CNMD Conmed
$86.47 /

+3.665 (+4.43%)

04/30/20 Piper Sandler
Conmed price target lowered to $90 from $110 at Piper Sandler
04/20/20 Piper Sandler
Conmed news positive for company, entire sector, says Piper Sandler
03/20/20 Piper Sandler
Conmed results to bounce back 'fairly quickly,' says Piper Sandler
03/10/20 Piper Sandler
Conmed price target lowered to $110 from $130 at Piper Sandler
CNMD Conmed
$86.47 /

+3.665 (+4.43%)

Hot Stocks
Conmed not providing FY20 guidance » 16:18
07/29/20
07/29
16:18
07/29/20
16:18
CNMD

Conmed

$86.46 /

+3.655 (+4.41%)

Due to the continued…

Due to the continued uncertainty created by the COVID-19 pandemic, management is unable to provide financial guidance at this time.

ShowHide Related Items >><<
CNMD Conmed
$86.46 /

+3.655 (+4.41%)

CNMD Conmed
$86.46 /

+3.655 (+4.41%)

04/30/20 Piper Sandler
Conmed price target lowered to $90 from $110 at Piper Sandler
04/20/20 Piper Sandler
Conmed news positive for company, entire sector, says Piper Sandler
03/20/20 Piper Sandler
Conmed results to bounce back 'fairly quickly,' says Piper Sandler
03/10/20 Piper Sandler
Conmed price target lowered to $110 from $130 at Piper Sandler
CNMD Conmed
$86.46 /

+3.655 (+4.41%)

Earnings
Conmed reports Q2 EPS (7c), consensus (95c) » 16:18
07/29/20
07/29
16:18
07/29/20
16:18
CNMD

Conmed

$86.46 /

+3.655 (+4.41%)

Reports Q2 revenue…

Reports Q2 revenue $157.8M, consensus $126.59M. Curt R. Hartman, CONMED's CEO says: "The month-over-month improvements in our revenue, profitability, and cash flow over the course of the quarter are encouraging signs. While we expect continued uncertainty as a result of the COVID-19 crisis, we feel well positioned as we enter the second half of 2020 and beyond."

ShowHide Related Items >><<
CNMD Conmed
$86.46 /

+3.655 (+4.41%)

CNMD Conmed
$86.46 /

+3.655 (+4.41%)

04/30/20 Piper Sandler
Conmed price target lowered to $90 from $110 at Piper Sandler
04/20/20 Piper Sandler
Conmed news positive for company, entire sector, says Piper Sandler
03/20/20 Piper Sandler
Conmed results to bounce back 'fairly quickly,' says Piper Sandler
03/10/20 Piper Sandler
Conmed price target lowered to $110 from $130 at Piper Sandler
CNMD Conmed
$86.46 /

+3.655 (+4.41%)

Over a quarter ago
Recommendations
Conmed price target lowered to $90 from $110 at Piper Sandler » 05:13
04/30/20
04/30
05:13
04/30/20
05:13
CNMD

Conmed

$74.34 /

+6.68 (+9.87%)

Piper Sandler analyst…

Piper Sandler analyst Matt O'Brien lowered the firm's price target on Conmed to $90 from $110 and keeps an Overweight rating on the shares. The company's Q1 results were impacted by the global spread of COVID-19 but its long-term opportunity remains, O'Brien tells investors in a research note.

ShowHide Related Items >><<
CNMD Conmed
$74.34 /

+6.68 (+9.87%)

04/20/20 Piper Sandler
Conmed news positive for company, entire sector, says Piper Sandler
03/20/20 Piper Sandler
Conmed results to bounce back 'fairly quickly,' says Piper Sandler
03/10/20 Piper Sandler
Conmed price target lowered to $110 from $130 at Piper Sandler
11/26/19 Needham
Conmed downgraded to Hold from Buy at Needham
Earnings
Conmed withdraws 2020 guidance » 16:06
04/29/20
04/29
16:06
04/29/20
16:06
CNMD

Conmed

$74.58 /

+6.92 (+10.23%)

Healthcare providers…

Healthcare providers around the globe have shifted their attention to caring for victims of the COVID-19 pandemic and preventing the spread of the virus, which has resulted in a deferral of surgical volumes. Due to the uncertainty created by this evolving dynamic, management has withdrawn its previously provided 2020 guidance, as announced on March 20, 2020, and is unable to provide reliable guidance at this time.

ShowHide Related Items >><<
CNMD Conmed
$74.58 /

+6.92 (+10.23%)

04/20/20 Piper Sandler
Conmed news positive for company, entire sector, says Piper Sandler
03/20/20 Piper Sandler
Conmed results to bounce back 'fairly quickly,' says Piper Sandler
03/10/20 Piper Sandler
Conmed price target lowered to $110 from $130 at Piper Sandler
11/26/19 Needham
Conmed downgraded to Hold from Buy at Needham
Earnings
Conmed reports Q1 adjusted EPS 51c, consensus 46c » 16:06
04/29/20
04/29
16:06
04/29/20
16:06
CNMD

Conmed

$74.58 /

+6.92 (+10.23%)

Reports Q1 revenue $214M,…

Reports Q1 revenue $214M, consensus $214.85M. "Our first quarter results were meaningfully impacted by the global COVID-19 pandemic, particularly during the second half of the quarter," commented Curt R. Hartman, CONMED's President and Chief Executive Officer. "While the current environment is challenging, we have taken decisive actions to protect our employees, solidify the financial security of the Company, and fortify the future of CONMED. Although we anticipate continued pressure in the near term, we believe our actions have positioned us to respond effectively when demand recovers."

ShowHide Related Items >><<
CNMD Conmed
$74.58 /

+6.92 (+10.23%)

04/20/20 Piper Sandler
Conmed news positive for company, entire sector, says Piper Sandler
03/20/20 Piper Sandler
Conmed results to bounce back 'fairly quickly,' says Piper Sandler
03/10/20 Piper Sandler
Conmed price target lowered to $110 from $130 at Piper Sandler
11/26/19 Needham
Conmed downgraded to Hold from Buy at Needham

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.